From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment

Author:

Meng Xianglong,Liu Xiaoqin,Tan Jiaying,Sheng Qi,Zhang Dingbang,Li Bin,Zhang Jia,Zhang Fayun,Chen Hongzhou,Cui Tao,Li Minghao,Zhang Shuosheng

Abstract

AbstractDiabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia resulting from insulin secretion defects or insulin resistance. The global incidence of DM has been gradually increasing due to improvements in living standards and changes in dietary habits, making it a major non-communicable disease that poses a significant threat to human health and life. The pathogenesis of DM remains incompletely understood till now, and current pharmacotherapeutic interventions are largely inadequate, resulting in relapses and severe adverse reactions. Although DM is not explicitly mentioned in traditional Chinese medicine (TCM) theory and clinical practice, it is often classified as “Xiaoke” due to similarities in etiology, pathogenesis, and symptoms. With its overall regulation, multiple targets, and personalized medication approach, TCM treatment can effectively alleviate the clinical manifestations of DM and prevent or treat its complications. Furthermore, TCM exhibits desirable therapeutic effects with minimal side effects and a favorable safety profile. This paper provides a comprehensive comparison and contrast of Xiaoke and DM by examining the involvement of TCM in their etiology, pathogenesis, treatment guidelines, and other relevant aspects based on classical literature and research reports. The current TCM experimental research on the treatment of DM by lowering blood glucose levels also be generalized. This innovative focus not only illuminates the role of TCM in DM treatment, but also underscores the potential of TCM in DM management.

Funder

the Shanxi applied basic research project

the projects of other provincial departments in Shanxi Province

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,Pharmacology

Reference202 articles.

1. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.

2. Report on Nutrition and Chronic Diseases in China (2020).Acta Nutrimenta Sinica. 2020; 42(06): 521.

3. Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013–2018 [published correction appears in JAMA. 2022 Mar 15;327(11):1093]. JAMA. 2021;326(24):2498–506. https://doi.org/10.1001/jama.2021.22208.

4. Wang T, Lu J, Shi L, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8(2):115–24. https://doi.org/10.1016/S2213-8587(19)30425-5.

5. Chinese Diabetes Society. Guidelines for the prevention and treatment of Type 2 diabetes mellitus in China (2020 Edition). Chin J Endocrinol Metab. 2021;37(04):311–98.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3